EYE - National Vision Hold... Stock Analysis | Stock Taper
Logo
National Vision Holdings, Inc.

EYE

National Vision Holdings, Inc. NASDAQ
$25.05 -0.50% (-0.13)

Market Cap $2.00 B
52w High $30.02
52w Low $10.75
P/E 65.91
Volume 776.54K
Outstanding Shares 79.44M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $503.41M $261.47M $3.32M 0.66% $0.04 $31.23M
Q3-2025 $487.33M $252.34M $3.37M 0.69% $0.04 $31.79M
Q2-2025 $486.42M $269.6M $8.72M 1.79% $0.11 $38.98M
Q1-2025 $510.32M $279M $14.19M 2.78% $0.18 $51.26M
Q4-2024 $437.28M $277.85M $-28.59M -6.54% $-0.36 $3.58M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $38.71M $2.13B $1.26B $869.53M
Q3-2025 $56.03M $1.96B $1.1B $858.76M
Q2-2025 $48.47M $1.97B $1.12B $850.58M
Q1-2025 $80.02M $2.01B $1.17B $836.16M
Q4-2024 $73.95M $2.01B $1.19B $816.33M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $-14.39M $13.16M $-24.32M $-6.11M $-17.32M $-11.24M
Q3-2025 $3.37M $46.63M $-19.36M $-19.68M $7.58M $30.27M
Q2-2025 $8.72M $54.26M $-12.7M $-73.42M $-31.86M $42.41M
Q1-2025 $14.19M $32.24M $-20.23M $-5.4M $6.61M $12.01M
Q4-2024 $-28.59M $30.28M $-33.73M $-3.99M $-7.44M $-1.74M

Revenue by Products

Product Q1-2025Q2-2025Q3-2025Q4-2025
Product Sales
Product Sales
$410.00M $390.00M $390.00M $400.00M
Services And Plans
Services And Plans
$100.00M $90.00M $90.00M $100.00M

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at National Vision Holdings, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Key positives include a large and established store base in a resilient category—vision correction is a recurring need rather than a discretionary luxury—paired with strong recognition in the value segment. The balance sheet shows substantial total assets and equity, suggesting real underlying scale, and historical retained earnings imply that the business has been profitable over time. Strategically, the company is investing in remote exam technology, AI‑based diagnostic tools, upgraded digital experiences, and a broader, more premium product mix, all of which can enhance customer experience and economics if executed well.

! Risks

The most immediate concern is the quality and implications of the recent financial data: the income statement provided points to extremely weak profitability and deeply negative gross margins, while the cash flow statement offers virtually no transparency on actual cash generation. Liquidity metrics look tight, with short‑term obligations seemingly outweighing readily available liquid assets, and a large goodwill balance adds the risk of future write‑downs if acquired businesses underperform. On top of this, the company must manage intense competition, price‑sensitive customers, staffing challenges in eye care, and the execution risk of shifting toward more premium offerings and sophisticated technology systems.

Outlook

The forward picture is mixed and highly dependent on information beyond this dataset. On one hand, National Vision operates in a structurally important market, has meaningful scale, and is actively modernizing its technology and product range, which could support gradual improvement in customer mix and operational effectiveness. On the other hand, the partial and internally inconsistent financials raise questions about near‑term profitability, cash flow, and balance‑sheet flexibility. Monitoring more complete filings for trends in same‑store sales, gross margin, operating cash flow, and leverage—as well as evidence of traction in its digital and tele‑optometry initiatives—will be crucial to forming a clearer view of its longer‑term trajectory.